BioCentury
ARTICLE | Company News

Evotec, Haplogen in discovery deal for infectious diseases

November 16, 2012 1:52 AM UTC

Evotec AG (Xetra:EVT) and Haplogen GmbH (Vienna, Austria) partnered to discover and develop small molecules against an undisclosed protein to treat viral infectious diseases. The protein was identifie...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article